Adaptimmune Therapeutics PLC - Ordinary Shares, par value GBP 0.001 per share (ADAPY)

64 filings reported holding ADAPY - Adaptimmune Therapeutics PLC - Ordinary Shares, par value GBP 0.001 per share as of Q2 2019.
Adaptimmune Therapeutics PLC - Ordinary Shares, par value GBP 0.001 per share (ADAPY) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 68,202,423 shares of 1,571,428,571 outstanding shares and own 4.3% of the company stock.
Largest 10 shareholders include Matrix Capital Management Company, LP (28,000,000 shares), NEA Management Company, LLC (15,832,611 shares), Capital World Investors (6,792,700 shares), BAILLIE GIFFORD & CO (4,143,840 shares), Man Group plc (1,839,225 shares), FMR LLC (1,578,783 shares), WELLINGTON MANAGEMENT GROUP LLP (1,500,127 shares), ORBIMED ADVISORS LLC (1,350,655 shares), MILLENNIUM MANAGEMENT LLC (1,319,292 shares), and Rock Springs Capital Management LP (875,000 shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.